home / stock / innpf / innpf articles

INNPF Articles, Innovative Properties Inc

Stock Information
Company Name: Innovative Properties Inc
Stock Symbol: INNPF
Market: OTC
Website: innocanpharma.com
Menu
INNPF INNPF Quote INNPF Short INNPF News INNPF Articles INNPF Message Board
Get INNPF Alerts

News, Short Squeeze, Breakout and More Instantly...
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark | Benzinga

InnoCan Pharma Corp. (OTCQB:INNPF) (CSE:INNO) (FSE: IP4) an Israel-based cannabinoids-focused pharmaceutical company, announced its interim consoli...
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain | Benzinga

Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND me...

CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval | Benzinga

Cannabinoids-focused pharmaceutical company Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTC:INNPF) said on Tuesday it expects its preliminary...

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 | Benzinga

Indigenous Leaders Lead The Way In Cannabis Regulation The Indigenous Cannabis Industry Association (ICIA) recently hosted its first Indigenous Can...
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It | Benzinga

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placem...

CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare | Benzinga

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporation as the sole agent ...

Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million | Benzinga

NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Sept. 21,...
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales | Benzinga

Innocan Pharma Corporation (CSE: INNO)(FSE: IP4) (OTC: INNPF), a pharmaceutical technology firm specializing in innovative drug delivery platforms,...

Next 10